Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

5-alpha reductase inhibitors may increase depression risk by 31%, but results vary based on comparison groups.

Blocking adenosine A2B receptor may prevent or treat hearing loss.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

Certain amino acids in 5AR1 and 5AR2 are crucial for binding and resistance to Finasteride.

AH-001 could be a safer and more effective treatment for hair loss.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

Avicequinone C, a compound found in the Avicennia marina plant, can reduce hair loss by inhibiting a hormone linked to androgenic alopecia.

Men taking dutasteride may have a higher risk of age-related macular degeneration.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.

5-ARI therapy may help prevent prostate cancer progression.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Combining low-dose dutasteride with finasteride improved a man's hair loss.

Aumolertinib effectively controls lung cancer and improves quality of life.

Combination therapy is more effective for prostate volumes over 60 ml.

A new treatment for hair loss shows promise with fewer side effects.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

Propranolol affects heart rate and renin levels in minoxidil-treated patients.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Alfatradiol (0.025%) is an effective and safe treatment for hair loss in both women and men.

Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.

Finasteride treatment makes the prostate look more like a healthy one.

Hydralazine and minoxidil are blood pressure medications that relax blood vessels, with potential side effects like rapid heartbeat and fluid retention, and are used for severe or pregnancy-related hypertension.